Compare Danaher Corporation (DHR) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Prologis Inc — how do they compare? Danaher Corporation trades at $198.81 (market cap $140.88B), while Prologis Inc trades at $142.49 (market cap $132.85B). The key difference: Danaher Corporation and Prologis Inc are close in size by market cap, and Prologis Inc pays the higher dividend (3%). Which is the better fit depends on your goals.
| DHR | PLD | |
|---|---|---|
Market Cap | $140.88B | $132.85B |
Sector | Health | Real Estate |
52-Week High | $242.05 | $148.74 |
52-Week Low | $161.91 | $104.08 |
Enterprise Value | $153.66B | $166.72B |
Dividend Yield | 0.8% | 3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
Prologis (PLD) trades at $142.16, up 0.92% today, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $1.05 exceeding expectations of $0.806. Recent news highlights expansion into data centers and a rejected $16.9 billion bid for Segro, indicating aggressive growth ambitions. Cash flow trends show operational strength despite a net outflow in 2025, while debt-to-asset ratios have risen to 37.2%.
The outlook remains positive with a consensus price target of $155.20, offering ~9% upside. Key risks include rising leverage, execution challenges in new segments, and macroeconomic sensitivity. Institutional sentiment is bullish, but investors should monitor debt levels and integration of strategic initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
